Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06162572 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06162572
- Sponsor
- Servier Bio-Innovation LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-07
- Primary completion
- 2027-04-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.